Exciting news alert!

Synoligo is ecstatic to announce our first collaboration of the year. We’re honored to join forces with N=1 Collaborative, an internationally acclaimed organization, on a mission to connect researchers, clinicians, physicians, patients, and drug developers worldwide under a standardized framework for individualized medicine. Their current initiative is to bring together experts in ASOs, RNA therapeutics, and CRISPR to pioneer new treatments.
At Synoligo, our mission is to empower scientific communities in advancing human health through high-quality oligonucleotide synthesis. Partnering with N1C aligns perfectly with our commitment to contribute to the breakthroughs in personalized medicine.
Join us in supporting N1C’s mission and making a difference in the lives of patients affected by rare diseases. Together, we aim for groundbreaking advancements in healthcare! 🚀